Does Childhood Eczema Harm School Performance? Two National Cohorts Offer Reassurance
Medically reviewed research summary. Educational only; not individualized medical advice.
A large question across two settings
Researchers linked population data from Denmark and England to examine whether childhood atopic dermatitis was associated with performance on compulsory national examinations around age 16. Together, the cohorts included 782,837 children, but their eczema definitions and education systems differed—an important feature for interpreting the results.
Denmark results
The Danish registry cohort included 776,214 children, of whom 10,259 had a hospital eczema diagnosis before age 13. Nonpassing grades occurred in 12.0% of children with eczema and 11.2% without it. After adjustment, the prevalence ratio was 1.06 (95% CI, 1.01–1.12), and the mean score difference was only −0.06 points (95% CI, −0.11 to −0.01). Active eczema was associated with a higher prevalence of nonpassing grades, but sibling comparisons produced similar overall conclusions.
England results
The English cohort included 6,623 children; 2,967 had repeated maternal reports of eczema. Nonpassing grades were less common in the eczema group, and adjusted mean scores were higher. Yet phenotype analyses suggested that this pattern was concentrated in moderate-declining and moderate-frequent trajectories, while mild-intermittent and severe-frequent eczema looked similar to the comparison group. These opposite national patterns argue against a simple causal claim.
What families should take from this
The investigators concluded that eczema was unlikely to be associated with meaningfully diminished academic performance overall. That is reassuring, but averages can hide individual difficulty. Nighttime itch, visible flares, bullying, anxiety, missed school and treatment demands can still disrupt a particular child.
Support the child, not just the score
Families can share a written care plan with the school, arrange access to prescribed treatment, reduce avoidable irritants and ask about accommodations when sleep or flares interfere. Persistent sleep loss, distress, infection signs or declining attendance deserve clinical and school support. For infants, seek pediatric guidance rather than extrapolating school-age data.
Bottom line
Across two very different cohorts, there was no consistent evidence of a large academic penalty from eczema itself. The most useful response is individualized support for symptoms, sleep and participation rather than assuming a child will struggle academically.
Continue the research
- QY201 phase 2 study
- Temtokibart phase 2a evidence
- Childhood eczema and standardized testing
- Patient-defined eczema treatment goals
- Minimal disease activity and quality of life
- Oral systemic treatment in practice
References
- Atopic dermatitis and academic performance: Denmark and England
- Standardized testing in 3,641 US children with eczema
- Educational and psychological interventions Cochrane review
- Atopic dermatitis and attention-deficit/hyperactivity disorder meta-analysis
- Sleep disturbances in children with atopic dermatitis
- Pediatric atopic dermatitis and sleep review
- Childhood eczema and mental health cohort study
- Atopic dermatitis and school absenteeism
- Family impact of childhood atopic dermatitis
- Pediatric eczema caregiver burden systematic review
- PEDISTAD pediatric disease burden registry
- Childhood atopic dermatitis and growth analysis
- International Eczema Council outcome consensus
- HOME core outcome set
- Patient-Oriented Eczema Measure validation
- RECAP long-term control instrument
- US pediatric eczema prevalence and burden
- Childhood eczema longitudinal trajectories
- Atopic dermatitis and depression/anxiety systematic review
- Pediatric atopic dermatitis quality-of-life review
- American Academy of Allergy, Asthma & Immunology/ACAAI GRADE guideline
- AAD topical therapy guideline
- Pediatric atopic dermatitis clinical practice guideline
- Atopic dermatitis clinical review